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A genetic progression model of head and neck squamous
cell carcinoma (HNSCC) has not yet been elucidated,
and the genetic basis for “field cancerization” has also
remained unclear. Most of the “field cancerization” has
been explained by the presence of cells with genetic
alterations, however, involvement of epigenetic altera-
tions in field cancerization was shown, too.
In the present study, paired specimens of tumour and
adjacent normal tissues were obtained from materials sur-
gically resected from 25 patients with squamous cell carci-
noma of the head and neck. After extraction of RNA,
quantitative RT-PCR method using 7300 TaqMan
(AppliedBiosystems) was used to analyze gene expression
of MGMT, p16, TIMP3. Next, we examined the associa-
tion between MGMT, p16, TIMP3 promoters methylation
and genes expression. The studies demonstrated higher
expression of p16 gene in tumour compared with adjacent
normal tissues. Other, MGMT and TIMP3 showed no dif-
ferences. Our results revealed no correlation between
MGMT, p16, TIMP3 promoters methylation level and
expression of these genes. Finally, we performed direct
DNA sequence analysis of MGMT somatic mutations
both in tumour and adjacent normal tissue. MGMT is a
300,000 bp-long gene that consist of six relatively short
exons. The gene is transcribed as a 1265 bp-long mRNA,
covering the 717 bp-long coding sequence. To facilitate
the screening of somatic mutations in the coding region of
the MGMT, a simple approach has been developed. As the
gene is expressed in HNSCC, we decided to amplify the
whole coding region of MGMT in two separate PCR reac-
tions using its cDNA as a template. The amplicons of indi-
vidual patients were labeled in PCR with MID identifiers
and sequenced using a medium-scale next generation
sequencing system, GS Junior (Roche/454). The method
developed can accurately identify low-level mutations,
down to a level of 5% of cells within the testing sample.
The lack of progress in head and neck oncology empha-
sizes the importance of molecular genetic studies to define
alterations that may correlate with tumor behavior.
Further studies may help clarify this issue.
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